Latest Biotechnology, Pharmaceutical and Healthcare News from Pharma-Voice

23:35 EDT 19th September 2019 | BioPortfolio

Here are the most relevant search results for "Pharma-Voice" found in our extensive news archives from over 250 global news sources.

More Information about Pharma-Voice on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pharma-Voice for you to read. Along with our medical data and news we also list Pharma-Voice Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pharma-Voice Companies for you to search.

Showing News Articles 1–25 of 41 from Pharma-Voice

Tuesday 17th September 2019

Specialty Data Aggregation: Preparing for a Successful Launch

By: Vincent Marino, Director of Strategic Partnerships, SHYFT Analytics The last decade has seen an explosion in the volume of patient-level data available to companies marketing specialty therapies. Drug manufacturers and industry business partners have responded by building and deploying innovative tools and strategies to maximize the utility of those data across life sciences organizations [...

Monday 16th September 2019

Everyone Wants Clinical Research Sites to Succeed – Now is the Time to Make it Happen

Given the rapid changes in #clinicalresearch, it can be challenging for sites to thrive & event grow. In this conference, we will focus on how to differentiate your site for success. Join WCG on Oct 7 in Philadelphia, PA to learn more: The post Everyone Wants Clinical Research Sites to Succeed – Now is the Time to Make it Happen appeared first on PharmaVOICE.

Friday 16th August 2019

Technology Drives the Rise of the Patient Voice in Drug Research

There’s an entirely new way to listen to patients, enabling researchers to better understand the patient experience by capturing authentic stories and translating sound science into actionable insights. This structured methodology combined with sociolinguistic analysis and AI-powered acoustic metrics provides unique emotion and customer insights that are used by major pharmaceutical companies, m...

Monday 8th July 2019

Evidera Policy Trends Update: CADTH Launches Parallel Scientific Advice Programs with NICE and Health Canada

In April 2019, members of Evidera’s Policy Trends team had the opportunity to speak with scientific staff members from the Canadian Agency for Drugs and Technologies in Health (CADTH) to discuss new opportunities available through CADTH’s scientific advice services. Read the fell article:  Key points in the paper: CADTH recently launched two parallel scientific [&...

Wednesday 19th June 2019

What are the Realities of VR and AR in the Industry?

This post contains excerpts from the June 2019 cover article in PharmaVOICE Magazine, written by Robin Robinson. Cognizant has been using AR technology at clinical congresses for several years, says Bryan Hill, chief technology officer, life sciences, Cognizant. One particular example involved an 80-foot artery that HCPs could access through an iPad and “walk” through […] The post What a...

How does disruptive innovation drive positive outcomes?

In the June Speak OUT feature in PharmaVOICE Magazine, Larissa Comis of Cognizant describes how the Cognizant Shared Investigator Platform is a disruptive innovation that can help companies achieve positive outcomes. Best Practices for Adopting the Shared Investigator Platform The Cognizant Shared Investigator Platform – SIP – is the disruptive innovation our industry sorely needs […] Th...

Monday 17th June 2019

The best technology in clinical research succeeds in the background

CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health( Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signant makes it easier to participate in – and sites and study teams to run – clinical trials. This intense focus on [...

Monday 3rd June 2019

How Digital Therapeutics Developers Can Satisfy Diverse Stakeholder Needs

If there are lingering doubts about the viability or market potential of digital therapeutics (DTx), recent moves by the U.S. Food & Drug Administration should lay them to rest. In December 2018, Pear Therapeutics and its partner, Novartis’ Sandoz unit, received FDA clearance for reSET-O, a prescription-only mobile medical app that helps patients with opioid […] The post How Digital Th...

Discover how the language of a disease changes over the patient’s journey

Listening and interpreting the patient’s views throughout their journey of care is an important and elusive goal. inVibe Labs has developed a lexicon guide for disease states, that helps shed some light on what a patient is saying about their care as they progress through their treatment with their HCP. Download “Speaking RA: Rheumatoid Arthritis […] The post Discover how the languag...

Tuesday 21st May 2019

Cultivating a good business relationship between agencies and clients

The importance of a good agency/client relationship cannot be overstated. In the May issue of PharmaVOICE magazine, Allison Davis of closerlook provides insights and advice into making this crucial relationship work. Read article Here are some of the highlights in this feature article: Learning each other’s communications styles Why being direct and asking for […...

Monday 20th May 2019

Clinical Outcome Assessment Selection for Rare Disease Trial Programs

Evidera has published an informative article to provide some baseline knowledge about the “why, who, what, and how” when it comes to clinical outcome assessments for rare disease trials. Read the article:  Key points in the paper: Patient inclusion throughout the drug development process is becoming a necessity. In rare disease product development, the […] ...

Monday 6th May 2019

What are Service Design Methods and how can they Transform Teams, Programs, and Services in Pharma?

An upcoming webinar explores Service Design Methods as a way of accelerating business objectives and improving the patient experience. Industry experts will share their knowledge and experiences on this topic, and will field questions from the audience after their presentation. Applying Service Design Methods to Transform Teams, Programs, and Services: An experience strategy primer to […] Th...

Machine Learning and the Future of Patient Forecasting in Clinical Trials

In a May 23 webinar, industry experts from Inteliquet will demonstrate specifically how machine learning can augment and assist human intelligence to perform better patient forecasting.  By extracting pertinent EMR information, including physicians’ notes, reading binary data from images and medical scans and comparing them to a study’s inclusion and exclusion criteria, machine learning can [...

Monday 29th April 2019

How Social Media Can Be Used to Understand What Matters to People with Rare Diseases

Evidera has released a white paper related to the January FDA revised draft guidance on rare and orphan drug development. The use of social media is recommended to help make the drug development process more efficient. This includes identifying rare disease patients for clinical trials, and learning more about the unmet needs, disease burden, opinions, […] The post How Social Media Can Be Us...

Thursday 25th April 2019

Children on the Front Line: The Toll of Rare Diseases – Executive Perspective

Read full article There are currently 350 million people worldwide suffering from rare diseases, and half of them are children. Parents are the strongest advocates for their children suffering with rare diseases, pushing researchers, companies and regulatory authorities to do more to save their loved ones. Industry experts weigh in on the challenges and […] The post Ch...

Monday 15th April 2019

Registries in Rare Disease Research – Approaches to Optimize Success

Submitted by:  Linda Ross, MPH, Senior Director, Peri- and Post-Approval Operations, Evidera Advancements in gene therapy and transformative medicine have had a major impact on the development of treatments for rare diseases, resulting in a growing need for evidence of the safety, effectiveness, and value of these treatments in the real world. Opportunities to improve […] The post Registri...

Monday 1st April 2019

Insights on Natural History Studies in Rare Diseases and Genetic Biomarkers

Provided by Evidera The increasing development of orphan drugs and precision medicine has led to novel needs in terms of real-world evidence generation. A key area recently highlighted in the FDA’s updated draft guidance on rare diseases is the recommendation of natural history studies to better characterize patient populations and delineate target populations. Natural history […] The post...

Targeting resistance to Immunotherapy with INB03

Provided by INmune Bio Primary and secondary resistance to therapy is a defining characteristic of progressive cancer in man. Patients and their clinical teams repeat the cycle of treatment, remission, relapse and retreatment until an effective therapy is found or the patient succumbs to the disease. Because of the devious biology of cancer, the “cure” […] The post Targeting resistance t...

Thursday 7th March 2019

Executive Perspective: A New Beginning – The Future of Global Communications

Contributed by: Matt Giegerich, CEO and Shaun Urban, President, The Inception Company Read the full article. When two veteran healthcare advertising executives decide to rejoin forces, the natural — and expected — assumption is that they would launch a new, differentiated, potentially funky, boutique-type communications agency. Well, M...

Monday 4th March 2019

A New Beginning: The Future of Global Communications

Executives reflect on the major shifts in the industry in the last 15 years and the evolving market dynamics that will impact global communication. Watch the video now Key points: Technology, digital, and data are driving change. The compression of time is a major factor in communications today. The shift from primary care brands […] The post A New Beginning: T...

Wednesday 20th February 2019

Red Zone: Disruptive Innovation: Questions for the C-Suite

Contributed by: Srini Shankar, Vice President, Life Sciences, Cognizant Read full article It is not the strongest of the species that survives, nor is it the most intelligent. It is the one that is most adaptable to change. Whether a direct quote from Charles Darwin or a summary of his writings, this statement is […] The post Red Zone: Disruptive Innovation: Questi...

Wednesday 13th February 2019

Executive Perspective: A Fused Model for the Enterprise – A Conversation with Brian Williams

See the results of a Forrester study on digital transformation Winning in today’s digital era requires more than just apps and a website. Fusing an enterprise for success in the digital era requires companies to seamlessly collaborate across the enterprise and create a true strategic pathway for a better customer experience. Recently, Cognizant commissioned […]...

Tuesday 22nd January 2019

Content that Clicks: Syneos Health Publishes Report on Social Media Marketing for Clinical Trial Recruitment

75% of Americans seek medical information online at least once a month—and yet, just 11% of clinical trials implement social-media efforts to recruit participants. Perhaps consequently, nearly half of all clinical trials fail to meet their target enrollment numbers. There is staggering potential for growth. To that end, Syneos Health conducted a study to determine, […] The post Content tha...

Tuesday 15th January 2019

Health Mindsets Report from Syneos Health: How to Diversify Marketing Efforts According to Consumer Healthcare Attitudes

That consumers are engaged with their own healthcare more now than ever before might make it all too easy to overlook how deeply their modes of engagement differ from one another. It sounds logical to assume that general engagement with information would reliably predict engagement with healthcare information, but a Syneos HealthTM survey uncovered exactly […] The post Health Mindsets Report...

Monday 14th January 2019

Top 5 reasons to use a Learning Management System for all your clinical trials

Download infographic now Establishing a training plan for all site and study staff is standard procedure for every clinical study. For regulatory compliance, sponsors need to track and provide documented evidence that allocated training has been completed by relevant team members. A recent infographic by ICON explains 5 key reasons for using a Learning […] The post Top...

Quick Search

News Quicklinks